Marriott Tina
Officer at RXRX
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 27
- Latest Oct 24, 2024
- Form 144 notices
- 21
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RXRXRECURSION PHARMACEUTICALS, INC.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale RXRXRoutineAug 29, 2024 2024
Sold 6,000 shares at $7.56 ($45k)
Marriott Tina, President and COO
10b5-1 planSold 1.1% of holdings ($4M position)521,138 shares left0.8x usual sizeFollows a Form 144Filing
- 2 Form 144 notice RXRXNoticeSep 26, 2024 +28 days
Filed to sell 6,000 shares ($42k)
Marriott Tina, Officer
10b5-1 plan0.9x usual sizeFiling
- 3 Form 4 sale RXRXRoutineSep 26, 2024 same day
Sold 6,000 shares at $7.00 ($42k)
Marriott Tina, President and COO
10b5-1 planSold 1.1% of holdings ($3.7M position)521,138 shares left0.9x usual sizeFollows a Form 144Filing
- 4 Form 144 notice RXRXNoticeOct 24, 2024 +28 days
Filed to sell 6,000 shares ($38k)
Marriott Tina, Officer
10b5-1 plan1x usual sizeFiling
- 5 Form 4 sale RXRXRoutineOct 24, 2024 same day
Sold 6,000 shares at $6.31 ($38k)
Marriott Tina, President and COO
10b5-1 planSold 1.1% of holdings ($3.3M position)521,138 shares left1x usual sizeFollows a Form 144Filing
- 6 Form 144 notice RXRXNoticeNov 21, 2024 +28 days
Filed to sell 6,000 shares ($35k)
Marriott Tina, Officer
10b5-1 planFirst sale on recordFiling
- 7 Form 144 notice RXRXNoticeDec 26, 2024 +35 days
Filed to sell 6,000 shares ($45k)
Marriott Tina, Officer
10b5-1 plan1x usual sizeFiling
- 8 Form 144 notice RXRXNoticeJan 30, 2025 +35 days
Filed to sell 6,000 shares ($45k)
Marriott Tina, Officer
10b5-1 plan1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (48)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Jan 30, 2025 | RXRX | Officer | Form 144 notice | 6,000 | $45k | Notice | SEC | |
| Dec 26, 2024 | Dec 26, 2024 | RXRX | Officer | Form 144 notice | 6,000 | $45k | Notice | SEC | |
| Nov 21, 2024 | Nov 21, 2024 | RXRX | Officer | Form 144 notice | 6,000 | $35k | Notice | SEC | |
| Oct 24, 2024 | Oct 28, 2024 | RXRX | President and COO | Form 4 sale | 6,000 | $38k | 1.1% | Routine | SEC |
| Oct 24, 2024 | Oct 24, 2024 | RXRX | Officer | Form 144 notice | 6,000 | $38k | Notice | SEC | |
| Sep 26, 2024 | Sep 30, 2024 | RXRX | President and COO | Form 4 sale | 6,000 | $42k | 1.1% | Routine | SEC |
| Sep 26, 2024 | Sep 26, 2024 | RXRX | Officer | Form 144 notice | 6,000 | $42k | Notice | SEC | |
| Aug 29, 2024 | Sep 3, 2024 | RXRX | President and COO | Form 4 sale | 6,000 | $45k | 1.1% | Routine | SEC |
| Aug 29, 2024 | Aug 29, 2024 | RXRX | Officer | Form 144 notice | 6,000 | $45k | Notice | SEC | |
| Jul 25, 2024 | Jul 29, 2024 | RXRX | President and COO | Form 4 sale | 6,000 | $49k | 1.1% | Routine | SEC |
| Jul 25, 2024 | Jul 25, 2024 | RXRX | Officer | Form 144 notice | 6,000 | $49k | Notice | SEC | |
| Jun 27, 2024 | Jun 28, 2024 | RXRX | President and COO | Form 4 sale | 6,000 | $43k | 1.1% | Routine | SEC |
| Jun 27, 2024 | Jun 27, 2024 | RXRX | Officer | Form 144 notice | 6,000 | $43k | Notice | SEC | |
| May 30, 2024 | Jun 3, 2024 | RXRX | President and COO | Form 4 sale | 3,000 | $26k | 0.6% | Routine | SEC |
| May 30, 2024 | May 30, 2024 | RXRX | Officer | Form 144 notice | 3,000 | $26k | Notice | SEC | |
| Apr 25, 2024 | Apr 29, 2024 | RXRX | President and COO | Form 4 sale | 3,000 | $23k | 0.5% | Routine | SEC |
| Apr 25, 2024 | Apr 25, 2024 | RXRX | Officer | Form 144 notice | 3,000 | $23k | Notice | SEC | |
| Mar 21, 2024 | Mar 25, 2024 | RXRX | President and COO | Form 4 sale | 8,000 | $86k | 1.2% | Routine | SEC |
| Mar 21, 2024 | Mar 21, 2024 | RXRX | Officer | Form 144 notice | 8,000 | $86k | Notice | SEC | |
| Feb 22, 2024 | Feb 23, 2024 | RXRX | President and COO | Form 4 sale | 8,000 | $119k | 1.2% | Routine | SEC |
| Feb 22, 2024 | Feb 22, 2024 | RXRX | Officer | Form 144 notice | 8,000 | $119k | Notice | SEC | |
| Jan 25, 2024 | Jan 29, 2024 | RXRX | President and COO | Form 4 sale | 8,000 | $83k | 1.9% | Routine | SEC |
| Jan 25, 2024 | Jan 25, 2024 | RXRX | Officer | Form 144 notice | 8,000 | $83k | Notice | SEC | |
| Dec 28, 2023 | Jan 2, 2024 | RXRX | President and COO | Form 4 sale | 8,000 | $85k | 1.9% | Routine | SEC |
| Dec 28, 2023 | Dec 28, 2023 | RXRX | Officer | Form 144 notice | 8,000 | $85k | Notice | SEC | |
| Nov 16, 2023 | Nov 17, 2023 | RXRX | President and COO | Form 4 sale | 3,000 | $20k | 0.7% | Routine | SEC |
| Nov 16, 2023 | Nov 16, 2023 | RXRX | Officer | Form 144 notice | 3,000 | $22k | Notice | SEC | |
| Oct 26, 2023 | Oct 30, 2023 | RXRX | President and COO | Form 4 sale | 3,000 | $17k | 0.7% | Routine | SEC |
| Oct 26, 2023 | Oct 26, 2023 | RXRX | Officer | Form 144 notice | 3,000 | $17k | Notice | SEC | |
| Sep 28, 2023 | Oct 2, 2023 | RXRX | President and COO | Form 4 sale | 3,000 | $23k | 0.7% | Routine | SEC |
| Sep 28, 2023 | Sep 28, 2023 | RXRX | Officer | Form 144 notice | 3,000 | $23k | Notice | SEC | |
| Aug 24, 2023 | Aug 28, 2023 | RXRX | President and COO | Form 4 sale | 3,000 | $26k | 0.7% | Routine | SEC |
| Aug 24, 2023 | Aug 24, 2023 | RXRX | Officer | Form 144 notice | 3,000 | $28k | Notice | SEC | |
| Jul 27, 2023 | Jul 28, 2023 | RXRX | President and COO | Form 4 sale | 8,000 | $109k | 1.9% | Routine | SEC |
| Jul 27, 2023 | Jul 27, 2023 | RXRX | Officer | Form 144 notice | 8,000 | $112k | Notice | SEC | |
| Jun 29, 2023 | Jul 3, 2023 | RXRX | President and COO | Form 4 sale | 3,000 | $22k | 0.7% | Routine | SEC |
| Jun 29, 2023 | Jun 29, 2023 | RXRX | Officer | Form 144 notice | 3,000 | $23k | Notice | SEC | |
| May 31, 2023 | Jun 2, 2023 | RXRX | President and COO | Form 4 sale | 3,000 | $26k | 0.7% | No plan | SEC |
| May 31, 2023 | May 31, 2023 | RXRX | Officer | Form 144 notice | 3,000 | $26k | Notice | SEC | |
| Feb 23, 2023 | Feb 27, 2023 | RXRX | President and COO | Form 4 sale | 8,000 | $63k | 1.8% | Plan not stated | SEC |
| Jan 26, 2023 | Jan 27, 2023 | RXRX | President and COO | Form 4 sale | 8,000 | $65k | 3.8% | Plan not stated | SEC |
| Dec 29, 2022 | Dec 30, 2022 | RXRX | President and COO | Form 4 sale | 8,000 | $62k | 3.8% | Plan not stated | SEC |
| Nov 17, 2022 | Nov 17, 2022 | RXRX | President and COO | Form 4 sale | 16,000 | $175k | 7.3% | Plan not stated | SEC |
| Oct 27, 2022 | Oct 28, 2022 | RXRX | President and COO | Form 4 sale | 16,000 | $172k | 7.2% | Plan not stated | SEC |
| Sep 29, 2022 | Oct 3, 2022 | RXRX | President and COO | Form 4 sale | 16,000 | $174k | 7.2% | Unusual | SEC |
| Aug 16, 2022 | Aug 17, 2022 | RXRX | President and COO | Form 4 sale | 16,000 | $202k | 5.1% | Plan not stated | SEC |
| Dec 16, 2021 | Dec 20, 2021 | RXRX | President and COO | Form 4 sale | 2,500 | $47k | 5.0% | Plan not stated | SEC |
| Nov 18, 2021 | Nov 22, 2021 | RXRX | President and COO | Form 4 sale | 2,500 | $47k | 4.8% | Plan not stated | SEC |